Search
Search
Proteintech
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Immunogen sequence: NQDLPVIKC VLINHKNNDS SVGKSSSYPM VSESPEDLGC ALRPQSSGTV YEAAAVEVDV SASITLQVLV DAPGNISCLW VFKHSSLNCQ PHFDLQNRGV VSMVILKMTE TQAGEYLLFI QSEATNYTIL FTVSIRNTLL YTLRRPYFRK MENQDALVCI SESVPEPIVE WVLCDSQGES CKEESPAVVK KEEKVLHELF GTDIRCCARN ELGRECTRLF TIDLNQTPQT TLPQLFLKVG EPLWIRCKAV HVNHGFGLTW ELENKALEEG NYFEMSTYST NRTMIRILFA FVSSVARNDT GYYTCSSSKH PSQSALVTIV EKGFINATNS SEDYEIDQYE EFCFSVRFKA Y (27-376 aa encoded by BC036028)
FLT3 is a tyrosine protein kinase that is a member of the growth factor receptor tyrosine kinase family. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
仅用于科研。不用于诊断过程。未经明确授权不得转售。